To access this element change to forms mode OFF
Grant Award View - GA216979
Understanding response and resistance to immunotherapy in...
GA ID:
GA216979
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
17-Oct-2021
Publish Date:
7-Feb-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$136,151.84
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Postgraduate Scholarships
Grant Activity:
Understanding response and resistance to immunotherapy in immunocompromised patients with cutaneous squamous cell carcinomas
Purpose:
Cutaneous squamous cell carcinoma (CSCC) is common in those with impaired immune systems and these patients have been excluded from the major immunotherapy trials. This research looks at CSCC that has improved or worsened on immunotherapy so we can better understand why some tumours respond and others do not. This will help assess who will benefit from immunotherapy, how we can fight resistance and improve treatment outcomes for vulnerable immunosuppressed patients.
GO ID:
GO Title:
2021 NHMRC Postgraduate Scholarship scheme
Internal Reference ID:
2021/GNT2013798
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA